News releases

ALL

Nov 09, 2021 other

other

Notice regarding Onsite Inspection at a Consolidated Subsidiary by the Japan Fair Trade Commission(109 KB)
Oct 27, 2021 product/service

product/service

Notice Regarding Approval of Partial Amendments to Indications, Dosage and Administration of Imatinib Tablets 100mg “KMP” for KYOSOMIRAI PHARMA(103 KB)
Oct 15, 2021 other

other

Notice Regarding Application for Selection of “Prime Market” in Tokyo Stock Exchange New Market Segments(76 KB)
Aug 26, 2021 stock

stock

Notice Regarding Completion of Payment Concerning Disposal of Treasury Stock as Restricted Stock Compensation(141 KB)
Aug 16, 2021 product/service

product/service

Notice Regarding Marketing Approvals for 1 Ingredient / 1 Product of Generic Drugs for KYOSOMIRAI PHARMA(147 KB)
Aug 06, 2021 performance

performance

Summary of Consolidated Financial Results for the First Quarter of Fiscal Year Ending March 31, 2022(379 KB)
Aug 02, 2021 product/service

product/service

Notice RegardingLaunch of 1 Ingredient/ 2 Products of Generic Drugs for KYOSOMIRAI PHARMA(110 KB)
Jul 27, 2021 stock

stock

Notice Regarding Disposal of Treasury Stock as Restricted Stock Compensation(201 KB)
Jun 30, 2021 other

other

Regarding a judgment on the violation of the Antimonopoly Act(58 KB)
Jun 29, 2021 corporate

corporate

Notice Regarding Change of Corporate Officers and Executive Appointment(165 KB)
Jun 18, 2021 product/service

product/service

Notice Regarding Launch of 3 Ingredients/ 6 Products of Generic Drugs for KYOSOMIRAI PHARMA(139 KB)
Jun 16, 2021 M&A/partnership

M&A/partnership

Notice Regarding Agreement for Business Alliance with Morimoto-Pharma Co., Ltd.(77 KB)
Jun 16, 2021 product/service

product/service

Notice Regarding Approval of Partial Amendments to Indications, Dosage and Administration of DULOXETINE Capsules 20mg/30mg “KMP” for KYOSOMIRAI PHARMA(126 KB)
May 26, 2021 M&A/partnership

M&A/partnership

Notice Regarding Business Succession by a Subsidiary(116 KB)